Position in CYTK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$760,150
+$190,161 QoQ
Shares Held
8,923
+3.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#280
of 477 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $48,601,060 across 36 Biotechnology names. CYTK ranks #15 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
89,139 | $10,104,797 | |
| 2 | ARGX |
Argenx SE
|
9,684 | $8,984,524 | |
| 3 | EXEL |
Exelixis, Inc.
|
74,817 | $4,070,792 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
10,755 | $3,064,852 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
51,220 | $2,930,808 | |
| 6 | BNTX |
BioNTech SE
|
20,934 | $1,947,908 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,237 | $1,743,899 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,828 | $1,404,752 |
All Filings in CYTK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $760,150 | 8,923 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $569,989 | 8,648 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $518,613 | 8,162 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $429,512 | 7,815 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $256,225 | 7,755 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $304,680 | 7,581 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $358,773 | 7,627 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $403,391 | 7,640 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $355,853 | 6,568 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $461,042 | 6,576 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $623,336 | 7,466 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $282 | 8,069 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $262,590 | 8,050 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $284,651 | 8,089 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $369,767 | 8,070 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $396,805 | 8,190 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $302,533 | 7,700 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $289,694 | 7,870 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $357,803 | 7,850 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $573,627 | 16,050 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $318,223 | 16,080 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $370,997 | 15,950 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $318,765 | 15,340 | Shares | Sole | 2021-01-14 | |
| No filing history on record for this holder in this stock. | ||||||